The Cancer Genome Atlas (TCGA): The next stage
The Cancer Genome Atlas (TCGA), the NIH research program that has helped set the standards for characterizing the genomic underpinnings of dozens of cancers on a large scale, is moving to its next phase.
TCGA Fourth Annual Scientific Symposium
Monday, May 11 - Tuesday, May 12, 2015 National Institutes of Health, Bethesda, Md. This open scientific meeting will consist of collaborative workshops, poster sessions, and plenary sessions.
Cancers Selected for Study
The Cancer Genome Atlas researchers are mapping the genetic changes in 20 cancers. Find out which cancers have been selected for study, the criteria for selection and the scientific questions being asked about each cancer.
Program Overview
Explore how The Cancer Genome Atlas works, the components of the TCGA Research Network and TCGA's place in the cancer genomics field in the Program Overview.
-
Leadership Update
-
July 2014
Steps Towards Precision Medicine: Utilizing FFPE Specimens for Comprehensive Genomic Characterization
Roy W. Tarnuzzer, Ph.D., the Biospecimen Core Resource Program Manager at the TCGA Program Office, provides an overview of the Formalin-fixed Paraffin Pilot Project, an initiative to investigate best practices for use of FFPE specimens in genomic studies.
View All
-
TCGA in Action
-
June 2014
CASE STUDY: Filling in the Gaps in the Catalog of Cancer Genes
Dr. Gad Getz and his group at the Broad Institute of MIT and Harvard identifies 33 new cancer-causing genes and finds that the catalog of cancer genes is far from complete. Learn more about the current cancer genome landscape in this Case Study. -
March 2014
CASE STUDY: The Cancer Digital Slide Archive: A Web Platform for Accessing TCGA Data
Dr. David Gutman and Dr. Lee Cooper developed The Cancer Digital Slide Archive (CDSA), a web platform for accessing pathology slide images of TCGA samples. Find out how they did it and how to use the CDSA website in this Case Study.
More Stories
-
News Releases and Announcements
- March 09, 2015
The Cancer Genome Atlas (TCGA): The next stage
The Cancer Genome Atlas (TCGA), the NIH research program that has helped set the standards for characterizing the genomic underpinnings of dozens of cancers on a large scale, is moving to its next phase. - January 27, 2015
NIH-funded study uncovers range of molecular alterations in head and neck cancers, new potential drug targets
TCGA tumor genome sequencing analyses offer new insights into the effects of HPV and smoking, and find genomic similarities with other cancers.
View All



